These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 7739317)

  • 41. Antifungal prophylaxis in solid organ transplant recipients.
    Brizendine KD; Vishin S; Baddley JW
    Expert Rev Anti Infect Ther; 2011 May; 9(5):571-81. PubMed ID: 21609268
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fluconazole prophylaxis in extremely low birth weight infants: association with cholestasis.
    Aghai ZH; Mudduluru M; Nakhla TA; Amendolia B; Longo D; Kemble N; Kaki S; Sutsko R; Saslow JG; Stahl GE
    J Perinatol; 2006 Sep; 26(9):550-5. PubMed ID: 16940972
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Diagnosis and treatment of fungal infection after liver transplantation.
    Shi XJ; Lü SC; He L; Lu F; Liang YR; Luo Y; Ji WB; Zhao ZM
    Chin Med J (Engl); 2011 Apr; 124(7):1015-7. PubMed ID: 21542960
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Prevention and treatment of invasive mycoses in patients with neutropenia and bone marrow transplantation].
    Burgaleta C
    Rev Clin Esp; 1995 Oct; 195 Suppl 3():31-7. PubMed ID: 9441303
    [No Abstract]   [Full Text] [Related]  

  • 45. Targeted short-term fluconazole prophylaxis among very low birth weight and extremely low birth weight infants.
    Uko S; Soghier LM; Vega M; Marsh J; Reinersman GT; Herring L; Dave VA; Nafday S; Brion LP
    Pediatrics; 2006 Apr; 117(4):1243-52. PubMed ID: 16585321
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antifungal prophylaxis in hematopoietic stem cell transplant recipients: the unfinished tale of imperfect success.
    Kontoyiannis DP
    Bone Marrow Transplant; 2011 Feb; 46(2):165-73. PubMed ID: 21042306
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A targeted peritransplant antifungal strategy for the prevention of invasive fungal disease after lung transplantation: a sequential cohort analysis.
    Koo S; Kubiak DW; Issa NC; Dietzek A; Boukedes S; Camp PC; Goldberg HJ; Baden LR; Fuhlbrigge AL; Marty FM
    Transplantation; 2012 Aug; 94(3):281-6. PubMed ID: 22790447
    [TBL] [Abstract][Full Text] [Related]  

  • 48. No difference between posaconazole and fluconazole antifungal prophylaxis and mycological diagnostics except costs in patients undergoing AML chemotherapy: a 1-year "real-life" evaluation.
    Bertz H; Drognitz K; Lübbert M
    Ann Hematol; 2014 Jan; 93(1):165-7. PubMed ID: 23949313
    [No Abstract]   [Full Text] [Related]  

  • 49. Management of acute liver failure.
    Williams R
    Postgrad Med J; 1988 Oct; 64(756):769-71. PubMed ID: 3076662
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fluconazole prophylaxis in patients with leukemia.
    Pavia AT; Riley DK
    Ann Intern Med; 1993 Nov; 119(9):951-2. PubMed ID: 8215009
    [No Abstract]   [Full Text] [Related]  

  • 51. Fluconazole prophylaxis in patients with leukemia.
    Akiyama H; Sakamaki H; Onozawa Y
    Ann Intern Med; 1993 Nov; 119(9):951; author reply 952. PubMed ID: 8215008
    [No Abstract]   [Full Text] [Related]  

  • 52. Fatal acute hepatic necrosis due to dose-dependent fluconazole hepatotoxicity.
    Bronstein JA; Gros P; Hernandez E; Larroque P; Molinié C
    Clin Infect Dis; 1997 Nov; 25(5):1266-7. PubMed ID: 9402409
    [No Abstract]   [Full Text] [Related]  

  • 53. Hepatocyte transplantation: back to the future.
    Gupta S; Chowdhary JR
    Hepatology; 1992 Jan; 15(1):156-62. PubMed ID: 1727791
    [No Abstract]   [Full Text] [Related]  

  • 54. Hepatic encephalopathy: classification and treatment.
    Bajaj JS
    J Hepatol; 2018 Apr; 68(4):838-839. PubMed ID: 29756596
    [No Abstract]   [Full Text] [Related]  

  • 55. [Reanimation of patients with liver diseases].
    Ciocatto E; Trompeo MA; Maritano M
    Epatologia; 1968 Oct; 14(5):405-21. PubMed ID: 5745487
    [No Abstract]   [Full Text] [Related]  

  • 56. The brain gets its say: Hepatic encephalopathy and its evolving role in transplant priority.
    Bajaj JS; Kamath PS
    Liver Transpl; 2016 Oct; 22(10):1319-20. PubMed ID: 27509240
    [No Abstract]   [Full Text] [Related]  

  • 57. The prevention of hepatic disorders.
    HAVENS WP
    Postgrad Med; 1956 Dec; 20(6):579-83. PubMed ID: 13379110
    [No Abstract]   [Full Text] [Related]  

  • 58. Liver disease.
    Nurs Stand; 2015 Nov; 30(10):17. PubMed ID: 26530565
    [No Abstract]   [Full Text] [Related]  

  • 59. [Liver protection therapy. 1].
    Koch H
    Pharm Unserer Zeit; 1980 Mar; 9(2):33-44. PubMed ID: 7367450
    [No Abstract]   [Full Text] [Related]  

  • 60. [Liver protective Therapy. 2].
    Koch H
    Pharm Unserer Zeit; 1980 May; 9(3):65-74. PubMed ID: 7403198
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.